Medicare Enrolled

Dr. Marie O'Brien, D.O.

Rheumatology · Allentown, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
3080 HAMILTON BLVD, Allentown, PA 18103
6107765038
In practice since 2007 (19 years)
NPI: 1083836464 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. O'Brien from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. O'Brien? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. O'Brien

Dr. Marie O'Brien is a rheumatology specialist in Allentown, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. O'Brien performed 16,621 Medicare services across 284 unique beneficiaries.

Between the years covered by Open Payments, Dr. O'Brien received a total of $6,173 from 23 pharmaceutical and/or device companies across 92 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. O'Brien is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 34% volume in PA $6,173 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,621
Medicare services
Top 34% in PA for rheumatology
284
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~875 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
13,200 $4 $21
Denosumab injection (Prolia/Xgeva) 3,120 $18 $48
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
66 $47 $145
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
63 $9 $65
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
63 $73 $299
New patient office visit, complex (60-74 min) 32 $146 $396
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
28 $38 $186
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
21 $93 $270
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
16 $62 $172
Telephone or electronic consultation, at least 5 minutes
A remote assessment and management service provided by a consulting physician via telephone, internet, or electronic health record. The service requires at least 5 minutes of time and includes a written report.
12 $28 $75
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,173
Total received (2018-2024)
Avg $882/year across 7 years
Top 38% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
92
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,522 (57.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,458 (39.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$193 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$370
2023
$142
2022
$334
2021
$260
2020
$424
2019
$3,875
2018
$768

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$245
Aurinia Pharma U.S., Inc.
$125
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$3,542
Amgen Inc.
$1,142
Janssen Scientific Affairs, LLC
$183
AbbVie, Inc.
$174
Aurinia Pharma U.S., Inc.
$163
AbbVie Inc.
$162
Genentech USA, Inc.
$155
Novartis Pharmaceuticals Corporation
$146
Kala Pharmaceuticals, Inc.
$93
Horizon Therapeutics plc
$72
UCB, Inc.
$59
PFIZER INC.
$54
Sandoz Inc.
$46
AstraZeneca Pharmaceuticals LP
$27
Sobi, Inc
$25
Boston Scientific Corporation
$25
Celgene Corporation
$22
Radius Health, Inc.
$20
Lilly USA, LLC
$15
ABBVIE INC.
$13
Horizon Pharma plc
$13
E.R. Squibb & Sons, L.L.C.
$12
GlaxoSmithKline, LLC.
$11
Top 3 companies account for 78.8% of all-time payments
Associated products mentioned in payments ›
Actemra · COSENTYX · Cimzia · EVENITY · Enbrel · HYRIMOZ · Humira · INVELTYS · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · NO_PRODUCT · NUCALA · ORENCIA · Otezla · PREVNAR 20 · Prolia · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · Tymlos · WATCHMAN · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (57%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a rheumatology specialist in Allentown?
Compare rheumatologists in the Allentown area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
26
Per 100K population
6.9
County median income
$77,493
Nearest hospital
LEHIGH VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. O'Brien is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. O'Brien experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. O'Brien performed 13,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. O'Brien receive payments from pharmaceutical companies?
Yes. Dr. O'Brien received a total of $6,173 from 23 companies across 92 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. O'Brien's costs compare to other rheumatologists in Allentown?
Dr. O'Brien's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. O'Brien) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →